VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Similar documents
VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTICONVULSANTS. Details

Step Therapy Requirements

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 03/01/2015

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements. Effective: 1/1/2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 11/01/2018

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Step Therapy Requirements. Effective: 12/01/2016

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

2017 Step Therapy Criteria

FirstCarolinaCare Insurance Company Step Therapy Requirements

ALLERGIC CONJUNCTIVITIS AGENTS

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

2018 Step Therapy Criteria

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

ANTICONVULSANT STEP THERAPY

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ALPHA GLUCOSIDASE INHIBITOR THERAPY

2019 PDP Basic Step Therapy Document

Step Therapy Medications

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

SelectHealth Advantage 2018 Step Therapy Criteria. Previous trial on at least ONE: Generic topical acne treatment. Previous trial on: alendronate

Alaska Medicaid 90 Day** Generic Prescription Medication List

2019 Simply Step Therapy Document

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

SmithRx Standard Formulary Step Therapy List

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

SelectHealth Advantage 2018 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

Step Therapy Group Algorithm Steps

**CRITERIA UNDER CMS REVIEW**

ATYPICAL ANTIPSYCHOTICS

Medications and Children Disorders

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)

ANTICONVULSANT THERAPY

Anticonvulsant Prior Authorization Request

STEP THERAPY CRITERIA

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Antiepileptics. Medications Comment Quantity Limit Carbamazepine. May be subject Preferred to quantity limit Epitol

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

SelectHealth Advantage 2019 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

ADHD STIMULANTS-S(SHC)

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

2018 Step Therapy FID 18088

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

New Patient Questionnaire

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Pharmacy Medical Necessity Guidelines: Anticonvulsants/Mood Stabilizers

Texas Prior Authorization Program Clinical Edit Criteria

Eligible Beneficiaries

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Step Therapy Criteria

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

ADHD STIMULANTS - SCORE

Buckeye Health Plan Medicaid Criteria Updates Q1 2017

Transcription:

Effective: 01/01/2017 Updated 11/2016

ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS.

ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA TROKENDI XR VIMPAT PRIOR CLAIM FOR GENERIC ANTICONVULSANT AGENT (CARBAMAZEPINE, DIVALPROEX SODIUM, GABAPENTIN, LAMOTRIGINE, LEVETIRACETAM, OXCARBAZEPINE, TIAGABINE, TOPIRAMATE, VALPROIC ACID, OR ZONISAMIDE), WITHIN THE PAST 120 DAYS.

ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI INVOKAMET INVOKANA JARDIANCE SYNJARDY PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE, TOLAZAMIDE, TOLBUTAMIDE), COMBINATION OF A SULFONYLUREA-METFORMIN, PIOGLITAZONE, OR A COMBINATION PIOGLITAZONE-METFORMIN OR PIOGLITAZONE- GLIMEPIRIDE WITHIN THE PAST 120 DAYS.

ANTIPSYCHOTIC AGENTS CLOZAPINE ODT FANAPT SAPHRIS VERSACLOZ VRAYLAR PRIOR CLAIM FOR FORMULARY VERSIONS OF ANY TWO ANTIPSYCHOTICS: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE, ARIPIPRAZOLE TABS/ODT WITHIN THE PAST 365 DAYS

ANTIPSYCHOTIC AGENTS II REXULTI PRIOR CLAIM FOR TWO (2) FORMULARY VERSIONS OF ATYPICAL ANTIPSYCHOTICS (RISPERIDONE, CLOZAPINE, OLANZAPINE, QUETIAPINE FUMARATE, ARIPIPRAZOLE OR ZIPRASIDONE) OR A SSRI (CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE) OR SNRI (VENLAFAXINE OR DULOXETINE) WITHIN THE PAST 365 DAYS

B VERSUS D ADMINISTRATIVE STEP CYCLOPHOSPHAMIDE METHOTREXATE TREXALL IN ORDER TO ASSIST IN A PART B VS. D PAYMENT DETERMINATION, A PRIOR CLAIM SEEN FOR A RHEUMATOID ARTHRITIS, PSORIASIS OR ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS DRUG WITHIN THE PAST 120 DAYS WILL QUALIFY FOR PART D PAYMENT. ALL OTHER INDICATIONS WILL HAVE A PART B VS. D PAYMENT DETERMINATION MADE THROUGH THE FORMULARY EXCEPTION PROCESS PRIOR TO THE APPROVAL OF THE DRUG.

BELBUCA BELBUCA PRIOR CLAIM FOR BUTRANS PATCH WITHIN THE PAST 120 DAYS.

CONTRACEPTIVES NUVARING PRIOR CLAIM FOR A GENERIC ORAL 21 OR 28 DAY CONTRACEPTIVE WITHIN THE PAST 120 DAYS. DOES NOT INCLUDE PLAN B OR PLAN B-ONE STEP OR THEIR GENERICS.

ELUXADOLINE VIBERZI PRIOR CLAIM FOR DICYCLOMINE AND XIFAXAN 550MG WITHIN THE PAST 120 DAYS.

FACTOR XA INHIBITORS PRADAXA PRIOR CLAIM FOR ELIQUIS AND XARELTO IN THE PAST 365 DAYS.

IVABRADINE CORLANOR PRIOR CLAIM FOR METOPROLOL SUCCINATE, BISOPROLOL OR CARVEDILOL WITHIN THE PAST 120 DAYS.

METFORMIN ER METFORMIN HCL ER PRIOR CLAIM FOR METFORMIN HCL ER TAB ER 24H (GENERIC GLUCOPHAGE XR) WITHIN THE PAST 120 DAYS.

OPHTHALMIC ANTIHISTAMINES - NO OTC ALREX PATADAY PRIOR CLAIM FOR LEVOCETIRIZINE, CROMOLYN SODIUM, EPINASTINE, OR OLOPATADINE 0.1% EYE DROPS WITHIN THE PAST 120 DAYS

QUETIAPINE FUMARATE EXTENDED RELEASE SEROQUEL XR PRIOR CLAIM FOR A FORMULARY VERSION OF ONE OF THE FOLLOWING: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE,CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, DULOXETINE, VENLAFAXINE, OR ARIPIPRAZOLE WITHIN THE PAST 365 DAYS.

RENIN ANGIOTENSION SYSTEM INHIBITORS AZOR TEKTURNA TEKTURNA HCT TRIBENZOR PRIOR CLAIM FOR AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE INHIBITOR), OR ACE INHIBITOR COMBINATION OR A GENERIC ANGIOTENSIN RECEPTOR BLOCKER (ARB), OR GENERIC ARB COMBINATION WITHIN THE PAST 120 DAYS.

SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIBITORS (SNRIS) FETZIMA PRISTIQ ER TRINTELLIX PRIOR CLAIM FOR PAROXETINE, FLUOXETINE, SERTRALINE, DULOXETINE, CITALOPRAM, MIRTAZAPINE, ESCITALOPRAM, OR BUPROPION (IR, SR, XL) WITHIN THE PAST 120 DAYS.

SPRITAM SPRITAM PRIOR CLAIM FOR LEVETIRACETAM SOLUTION IN THE PAST 120 DAYS

ZARXIO ZARXIO MUST HAVE PREVIOUSLY TRIED NEUPOGEN PRIOR TO ZARXIO